IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees

While the RV144 HIV vaccine trial led to moderately reduced risk of HIV acquisition, emerging data from the HVTN702 trial point to the critical need to reexamine RV144-based correlates of reduced risk of protection. While in RV144, the induction of V2-binding, non-IgA, IgG3 antibody responses with n...

全面介紹

Na minha lista:
書目詳細資料
發表在:JCI Insight
Main Authors: Fischinger, Stephanie, Dolatshahi, Sepideh, Jennewein, Madeleine F., Rerks-Ngarm, Supachai, Pitisuttithum, Punnee, Nitayaphan, Sorachai, Michael, Nelson, Vasan, Sandhya, Ackerman, Margaret E., Streeck, Hendrik, Alter, Galit
格式: Artigo
語言:Inglês
出版: American Society for Clinical Investigation 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7710302/
https://ncbi.nlm.nih.gov/pubmed/33031099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.140925
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍